DexCom
DXCM
DXCM
414 hedge funds and large institutions have $10.5B invested in DexCom in 2018 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 153 increasing their positions, 117 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3% less call options, than puts
Call options by funds: $25.8M | Put options by funds: $26.7M
4.33% less ownership
Funds ownership: 401.9% → 397.57% (-4.3%)
17% less capital invested
Capital invested by funds: $12.7B → $10.5B (-$2.19B)
Holders
414
Holding in Top 10
11
Calls
$25.8M
Puts
$26.7M
Top Buyers
| 1 | +$218M | |
| 2 | +$119M | |
| 3 | +$111M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84.4M |
| 5 |
Two Sigma Advisers
New York
|
+$78M |
Top Sellers
| 1 | -$473M | |
| 2 | -$229M | |
| 3 | -$156M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$88M |
| 5 |
O
OppenheimerFunds
New York
|
-$83.3M |